Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection-Reference-Cited by-同舟云学术

Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection

Published:2012-09-01 Issue:1 Volume:61 Page:73-77
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Gotuzzo Eduardo,Markowitz Martin,Ratanasuwan Winai,Smith Graham,Prada Guillermo,Morales-Ramirez Javier O.,Strohmaier Kim M.,Lu Chengxing,Bhanja Sanhita,Nguyen Bach-Yen,Teppler Hedy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference18 articles.

1. . Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells.;Hazuda;Science,2000

2. . Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.;Markowitz;J Acquir Immune Defic Syndr,2006

3. . Rapid and durable antiretroviral effect of the HIV-1 integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.;Markowitz;J Acquir Immune Defic Syndr,2007

4. . Sustained antiretroviral efficacy of raltegravir as part of combination antiretroviral therapy in treatment-naive HIV-1 infected patients: 96-week data.;Markowitz;J Acquir Immune Defic Syndr,2009

5. . Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.;Lennox;Lancet,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy;Medicine;2019-06

2. Association of raltegravir use with long-term health outcomes in HIV-infected patients: an observational post-licensure safety study in a large integrated healthcare system;HIV Clinical Trials;2018-09-03

3. HIV/AIDS Comorbidities: Impact on Cancer, Noncommunicable Diseases, and Reproductive Health;Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases;2017-11-06

4. HIV INTEGRASE INHIBITORS: THE BASIS OF EFFECTIVE AND SAFE ANTIRETROVIRAL THERAPY;Medical Council;2017-05-26

5. The Role of Metabolizing Enzymes and Transporters in Antiretroviral Therapy;Current Topics in Medicinal Chemistry;2016-11-24